IP Library › Assignment 045022/0976
Patent Assignment
Reel/Frame 045022/0976

Security Interest

Recorded: 2018-02-23 Pages: 17
Assignor
BIODESIX, INC.
Executed: 2018-02-23
Assignee
INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
777 THIRD AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties (39)
Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
Patent: 9,653,272 →
Application: 13/835,909 →
Publication: US 2013/0344111
Method and System for Validation of Mass Spectrometer Machine Performance
Patent: 8,467,988 →
Application: 13/733,018 →
Method for treating and identifying lung cancer patients likely to benefit from EGFR inhibitor and a monoclonal antibody HGF inhibitor combination therapy
Application: 14/678,428 →
Publication: US 2015/0285817
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
Application: 14/868,615 →
Publication: US 2016/0019342
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Patent: 9,779,204 →
Application: 14/869,348 →
Publication: US 2016/0098514
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Application: 15/701,668 →
Publication: US 2018/0129780
Method of predicting development and severity of graft-versus-host disease
Patent: 9,563,744 →
Application: 14/949,229 →
Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF Mass Spectrometry
Application: 14/936,847 →
Publication: US 2016/0163522
Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample
Application: 14/946,045 →
System and Method for Three-Dimensional Nerve Segmentation Using Curved Multiplanar Reformatting Magnetic Resonance Imaging
Patent: 9,971,952 →
Application: 15/019,417 →
Publication: US 2016/0232664
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
Application: 15/207,825 →
Publication: US 2017/0039345
Method for Identification of Cancer Patients with Durable Benefit from Immunotherapy in Overall Poor Prognosis Subgroups
Application: 62/442,557 →
Diagnostic Test Stystem for Specific, Sensitive and Reproducible Detection of Circulating Nucleic Acids in Whole Blood
Application: 62/442,578 →
Diagnostic Test Stystem for Specific, Sensitive and Reproducible Detection of Circulating Nucleic Acids in Whole Blood
Application: 15/862,896 →
Publication: US 2018/0202005
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Patent: 7,736,905 →
Application: 11/396,328 →
Publication: US 2007/0231921
Selection of Colorectal Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Patent: 7,858,390 →
Application: 12/321,394 →
Publication: US 2009/0170216
Selection of Head and Neck Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Patent: 7,867,775 →
Application: 12/321,393 →
Publication: US 2009/0171872
Selection of Non-Small-Cell Lung Cancer Patients for Treatment with Monoclonal Antibody Drugs Targeting Egfr Pathway
Patent: 7,858,389 →
Application: 12/321,392 →
Publication: US 2009/0170215
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Patent: 7,879,620 →
Application: 12/661,129 →
Publication: US 2010/0204061
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Patent: 9,824,182 →
Application: 12/806,137 →
Publication: US 2010/0305868
Method and system for determining whether a drug will be effective on a patient with a disease
Patent: 9,152,758 →
Application: 13/373,336 →
Publication: US 2012/0089341
Method for Reliable Classification of Samples in Clinical Diagnostics Using an Improved Method of Classification
Patent: 8,024,282 →
Application: 12/218,519 →
Publication: US 2008/0306898
Monitoring Treatment of Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Patent: 7,906,342 →
Application: 12/584,594 →
Publication: US 2010/0055100
Monitoring Treatment of Colorectal Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Patent: 8,119,418 →
Application: 12/931,324 →
Publication: US 2011/0121169
Monitoring Treatment of Head and Neck Cancer Patients with Drugs Egfr Pathway Using Mass Spectrometry of Patient Samples
Patent: 8,119,417 →
Application: 12/931,322 →
Publication: US 2011/0121168
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Patent: 8,586,379 →
Application: 13/313,791 →
Publication: US 2012/0074310
Monitoring treatment of Head and Neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Patent: 8,586,380 →
Application: 13/313,838 →
Publication: US 2012/0074311
A Method for Predicting Breast Cancer Patient Response to Endocrine Therapy
Patent: 8,914,238 →
Application: 13/356,730 →
Publication: US 2012/0193525
A Method for Predicting Breast Cancer Patient Response to Combination Therapy
Patent: 9,254,120 →
Application: 13/741,634 →
Publication: US 2013/0131996
Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents
Patent: 8,718,996 →
Application: 13/836,064 →
Publication: US 2014/0012514
Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
Patent: 9,279,798 →
Application: 13/836,436 →
Publication: US 2013/0320203
Deep MALDI TOF Mass Spectrometry of Complex Biological Samples, e.g., Serum, and Uses Thereof
Patent: 9,606,101 →
Application: 14/868,575 →
Publication: US 2016/0018410
Classification Generation Method Using Combination of Mini-Classifiers with Regularization and Uses Thereof
Patent: 9,477,906 →
Application: 14/486,442 →
Publication: US 2015/0102216
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
Patent: 9,211,314 →
Application: 14/460,769 →
Publication: US 2015/0283206
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Predictive Test for Melanoma Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-Cell Programmed Cell Death 1 (Pd-1) Checkpoint Protein and Classifier Development Methods
Predictive Test for Melanoma Patient Benefit from Interleukin-2 (IL2) Therapy
Classifier Generation Methods and Predictive Test for Ovarian Cancer Patient Prognosis Under Platinum Chemotherapy
Method for Identification of Cancer Patients with Durable Benefit from Immunotherapy in Overall Poor Prognosis Subgroups
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 16, 2007
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC., A DELAWARE CORPORATION
Reel/Frame 019021/0827 →
Assignment of Assignor's Interest Mar 2, 2009
From: ROEDER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0985 →
Assignment of Assignor's Interest Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022349/0058 →
Assignment of Assignor's Interest Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0989 →
Assignment of Assignor's Interest Jan 8, 2013
From: RODER, JOANNA; RODER, HEINRICH; TSYPIN, MAXIM
To: BIODESIX, INC.
Reel/Frame 029584/0788 →
Assignment of Assignor's Interest Apr 8, 2013
From: RODER, JOANNA; RODER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 030169/0868 →
Assignment of Part Interest Apr 12, 2013
From: BIODESIX, INC.
To: GLOBEIMMUNE, INC.
Reel/Frame 030205/0346 →
Short-Form Patent Security Agreement Dec 3, 2013
From: BIODESIX, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031751/0694 →
Assignment of Assignor's Interest Apr 17, 2015
From: RODER, HEINRICH; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 035435/0539 →
Assignment of Assignor's Interest Sep 29, 2015
From: RÖDER, HEINRICH; RÖDER, JOANNA
To: BIODESIX, INC.
Reel/Frame 036679/0897 →
Assignment of Assignor's Interest Sep 30, 2015
From: RÖDER, JOANN; RÖDER, HEINRICH; OLIVEIRA, CARLOS
To: BIODESIX, INC.
Reel/Frame 036693/0666 →
Assignment of Assignor's Interest Nov 7, 2015
From: HAN, MAY; KOMARNITSKY, PHILIP; GYURIS, JENO
To: AVEO PHARMACEUTICALS, INC.
Reel/Frame 036984/0459 →
Assignment of Assignor's Interest Nov 20, 2015
From: STEINGRIMSSON, ARNI; RÖDER, HEINRICH; RÖDER, JOANNA
To: BIODESIX, INC.
Reel/Frame 037097/0889 →
Assignment of Assignor's Interest Dec 1, 2015
From: RÖDER, HEINRICH; RÖDER, JOANNA
To: BIODESIX, INC.
Reel/Frame 037176/0052 →
Assignment of Assignor's Interest Jan 21, 2016
From: RÖDER, JOANNA; OLIVEIRA, CARLOS; GRIGORIEVA, JULIA; RÖDER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 037548/0232 →
Assignment of Assignor's Interest Aug 10, 2016
From: RODER, JOANNA; MEYER, KRISTA; GRIGORIEVA, JULIA; TSYPIN, MAXIM
To: BIODESIX INC.
Reel/Frame 039398/0069 →
Assignment of Assignor's Interest Jan 25, 2017
From: MELLERT, HESTIA; JACKSON, LEISA; PESTANO, GARY A.
To: BIODESIX, INC.
Reel/Frame 041085/0166 →
Assignment of Assignor's Interest Feb 24, 2017
From: OLIVEIRA, CARLOS; RODER, HEINRICH; GRIGORIEVA, JULIA; RODER, JOANNA
To: BIODESIX INC.
Reel/Frame 041366/0056 →
Assignment of Assignor's Interest Sep 12, 2017
From: RODER, JOANNA; RODER, HEINRICH; OLIVEIRA, CARLOS
To: BIODESIX INC.
Reel/Frame 043559/0436 →
Assignment of Assignor's Interest Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044813/0947 →
Assignment of Assignor's Interest Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044815/0024 →
Assignment of Assignor's Interest Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044818/0967 →
Assignment of Assignor's Interest Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0024 →
Assignment of Assignor's Interest Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0010 →
Assignment of Assignor's Interest Feb 5, 2018
From: RODER, HEINRICH; RODER, JOANNE
To: BIODESIX INC.
Reel/Frame 044831/0205 →